Target |
Mechanism IL-12R stimulants [+2] |
Active Org. |
Originator Org. Virogin Biotech Ltd.Startup |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism IL-12R stimulants [+1] |
Active Org. Virogin Biotech Ltd.Startup |
Originator Org. Virogin Biotech Ltd.Startup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism IL-12R stimulants [+1] |
Active Org.- |
Originator Org. Torque Therapeutics, Inc.Startup |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date24 Jan 2024 |
Sponsor / Collaborator Virogin Biotech Ltd.Startup |
Start Date04 Dec 2023 |
Sponsor / Collaborator |